Photodynamic therapy in the treatment of circumscribed choroidal hemangioma: Current perspectives

被引：10

作者：

Kumar, Ashok ^{[1
]}

Shankar, Sandeep ^{[1
]}

Singh, Ankita ^{[1
]}

Mishra, Sanjay ^{[2
]}

Kumar, Poninder ^{[1
]}

Arora, Amit ^{[1
]}

机构：

[1] Armed Forces Med Coll, Dept Ophthalmol, Pune 411040, Maharashtra, India

[2] Army Hosp Res & Referral, Dept Ophthalmol, New Delhi 110010, India

来源：

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY | 2022年 / 39卷

关键词：

Photodynamic therapy; Choroidal hemangioma; Half dose; Review; GAMMA-KNIFE RADIOSURGERY; TRANSPUPILLARY THERMOTHERAPY; VERTEPORFIN; EFFICACY; NEOVASCULARIZATION; PHOTOCOAGULATION; IRRADIATION; MECHANISMS; FEATURES;

D O I：

10.1016/j.pdpdt.2022.103000

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Photodynamic therapy (PDT) using verteporfin Visudyne((R))(Novartis International AG, Basel, Switzerland) is widely used to treat various chorio-retinal diseases. PDT targets choroidal vascular abnormalities and induces selective occlusion of vessels. PDT was originally used in combination with full-dose verteporfin to treat neovascular age-related macular degeneration. Currently, the clinical targets of PDT have shifted to other chorioretinal conditions such as central serous chorioretinopathy, polypoidal choroidal vasculopathy and choroidal hemangioma. Clinical studies have also facilitated the optimization of treatment outcomes in choroidal hemangiomas through changes in protocols including the introduction of reduced treatment settings; such as PDT with half-dose verteporfin and half-fluence PDT. Here, we review various evolving trends in clinical application of PDT and its use for choroidal hemangiomas from a practical perspective.

引用

页数：6

共 57 条

[1] NODULAR POSTERIOR SCLERITIS Clinico-Sonographic Characteristics and Proposed Diagnostic Criteria [J].

Agrawal, Rupesh ;

Lavric, Alenka ;

Restori, Marie ;

Pavesio, Carlos ;

Sagoo, Mandeep S. .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (02) :392-401

[2] Palladium 103 (103Pd) plaque for circumscribed choroidal hemangioma with retinal detachment radiation therapy [J].

Aizman, A ;

Finger, PT ;

Shabto, U ;

Szechter, A ;

Berson, A .

ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (11) :1652-1656

[3] Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy [J].

Alkin, Zeynep ;

Perente, Irfan ;

Ozkaya, Abdullah ;

Alp, Dilek ;

Agca, Alper ;

Aygit, Ebru Demet ;

Korkmaz, Selcuk ;

Yazici, Ahmet Taylan ;

Demirok, Ahmet .

CLINICAL OPHTHALMOLOGY, 2014, 8 :685-690

[4]

[Anonymous], 1999, Arch Ophthalmol, V117, P1329

[5] Circumscribed choroidal hemangioma: Characteristic features with indocyanine green videoangiography [J].

Arevalo, JF ;

Shields, CL ;

Shields, JA ;

Hykin, PG ;

De Potter, P .

OPHTHALMOLOGY, 2000, 107 (02) :344-350

[6]

Berry Morgan, 2017, J Optom, V10, P79, DOI 10.1016/j.optom.2015.12.006

[7] Photodynamic Therapy in Ocular Oncology [J].

Blasi, Maria Antonietta ;

Pagliara, Monica Maria ;

Lanza, Angela ;

Sammarco, Maria Grazia ;

Caputo, Carmela Grazia ;

Grimaldi, Gabriela ;

Scupola, Andrea .

BIOMEDICINES, 2018, 6 (01)

[8] Prospective Clinical Trial Evaluating the Efficacy of Photodynamic Therapy for Symptomatic Circumscribed Choroidal Hemangioma [J].

Boixadera, Anna ;

Garcia Arumi, Jose ;

Martinez-Castillo, Vicente ;

Luis Encinas, Jose ;

Elizalde, Javier ;

Blanco-Mateos, Gonzalo ;

Caminal, Jose ;

Capeans, Carmela ;

Armada, Felix ;

Navea, Amaparo ;

Luis Olea, Jose .

OPHTHALMOLOGY, 2009, 116 (01) :100-105

[9] Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne®), in the CAM model [J].

Debefve, E. ;

Pegaz, B. ;

van den Bergh, H. ;

Wagnieres, G. ;

Lange, N. ;

Ballini, J. -P. .

ANGIOGENESIS, 2008, 11 (03) :235-243

[10] Photodynamic therapy for cancer [J].

Dolmans, DEJGJ ;

Fukumura, D ;

Jain, RK .

NATURE REVIEWS CANCER, 2003, 3 (05) :380-387

← 1 2 3 4 5 6 →